Cryptorchidism: Aspects of Fertility and Neoplasms
Cortes D. · Thorup J.M. · Visfeldt J.
A Study Including Data of 1,335 Consecutive Boys Who Underwent Testicular Biopsy Simultaneously with Surgery for Cryptorchidism
Departments of Pediatric Surgery and Pathology, Rigshospitalet, Denmark
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Purpose: An attempt to make a rational strategy for treatment of cryptorchidism. Materials and Methods: 1,335 cryptorchid boys with biopsy at surgery (1,638 specimens). We studied: frequency of no germ cells in biopsies from 698 patients <12 years at surgery; fertility potential of 140 patients who were now adults, and apperance of testicular neoplasia in all biopsies. Results: Lack of germ cells appeared from 18 months. The frequency increased with increasing age. It appeared in 30% (61/202) bilateral, and 18% (88/496) unilateral cases. In men who had undergone bilateral or unilateral orchiopexy, respectively, there was normal sperm count in 19% (14/75) and 83% (54/65), and infertility was suspected in 56% (42/75) and 8% (5/65) (FE, p < 0.00005, p < 0.00005), respectively. The lowest, the mean, and the highest age-matched spermatogonia count per tubule at orchiopexy was associated with sperm count (Spearman test, p < 0.0001, p < 0.005, p < 0.05). Isolated, this was demonstrated for the 75 formerly bilateral (Spearman, p < 0.0001, p < 0.0001, p < 0.0001), but not the 65 formerly unilateral cases (Spearman, p = 1.0). No germ cells at orchiopexy was associated with suspected infertility. Risk was 78–100% in bilateral (dependent on one or both testes affected), and 33% in unilateral cryptorchidism. There was one invasive germ cell tumor, six cases of carcinoma in situ testis, and one Sertoli cell tumor. Three neoplasms were diagnosed in intra-abdominal testes, four in boys with abnormal external genitalia, and two in boys with known abnormal karyotype. Risk of neoplasia was 5% (7/150) in patients with intra-abdominal testis, abnormal external genitalia or diagnosed abnormal karyotype, versus 0% (0/1,185) in patients without these characteristics (FE, p < 0.00005). Conclusion: We recommend surgery for cryptorchidism before 15–18 months of age because: (a) lack of germ cells is very rare before, and (b) lack of germ cells is associated with subsequent risk of infertility. At primary surgery for cryptorchidism, we recommend examination for testicular neoplasia in cases of intra-abdominal testis, abnormal external genitalia or known abnormal karyotype.
© 2001 S. Karger AG, Basel
Cortes D: Cryptorchidism: Aspects of pathogenesis, histology and treatment. Scand J Urol Nephrol 1999;32(suppl 196):1–54.
Hadziselimovic F, Herzog B, Buser M: Development of cryptorchid testes. Eur J Pediatr 1987;146(suppl 2):S8.
- Kogan SJ, Tennenbaum S, Gill B, Reda E, Levitt SB: Efficacy of orchiopexy by patient age 1 year for cryptorchidism. J Urol 1990;144:508.
Schindler AM, Diaz P, Cuendet A, Sizonenko PC: Cryptorchidism: A morphological study of 670 biopsies. Helv Paediatr Acta 1987;155:1644.
Cortes D, Thorup J: Histology of testicular biopsies taken at operation for bilaterally maldescended testes in relation to fertility in adulthood. Br J Urol 1990;68:285.
Cortes D, Thorup JM, Lindenberg S: Fertility potential after unilateral orchiopexy: Simultaneous testicular biopsy and orchiopexy in a cohort of 87 patients. J Urol 1996;155:1096.
- Cortes D, Thorup JM, Lindenberg S: Fertility potential after unilateral orchiopexy: An age-independent risk of subsequent infertility when biopsies at surgery lack germ cells. J Urol 1996;156:217.
- Cortes D, Visfeldt J, Møller H, Thorup J: Testicular neoplasia in cryptorchid boys at primary surgery: Case series. BMJ 1999;319:888.
- Hadziselimovic F, Hecker E, Herzog B: The value of testicular biopsy in cryptorchidism. Urol Res 1984;12:171.
Mayr J, Pusch HH, Schimpl G, Reitinger T, Sorantin E, Mayr-Koci M: Semen quality and gonadotropin levels in patients operated upon for cryptorchidism. Pediatr Surg Int 1996;11:354.
- Engeler DS, Hösli PO, John H, Bannwart F, Sulser T, Amin MB, Heitz PU, Hailemariam S: Early orchiopexy: Prepubertal intratubular germ cell neoplasia and fertility outcome. Urology 2000;56:144.
- Lee P, Coughlin T, Bellinger MF: Paternity and hormone levels after unilateral cryptorchidism: Association with pretreatment testicular location. J Urol 2000;164:1697.
- Foresta C, Moro E, Garolla A, Onisto M, Ferlin A: Y chromosome microdeletions in cryptorchidism and idiopathic infertility. J Clin Endocr Metab 1999;84:3660.
- Cortes D, Thorup JM, Visfeldt J, Schwartz M: Is infertility after surgery for cryptorchidism congenital or acquired? Pediatr Surg Int 1998;14:6.
- Fagerli J, Schneck FX, Lee PA, Bellinger MF, Witchel SF: Absence of microdeletions in the Y chromosome in patients with a history of cryptorchidism and azoospermia or oligospermia. Fertil Steril 1999;71:697.
- Mieusset R, Bujan L: The potential of mild testicular heating as a safe, effective and reversible contraceptive method for men. Int J Androl 1994;17:186.
- Okuyama A, Nonomura N, Nakamura M, Namiki M, Fujioka H, Kiyohara H, Matsumoto K, Sonoda T: Surgical management of undescended testis: Retrospective study of potential fertility in 274 cases. J Urol 1989;142:749.
Bergman M, Behre HM, Nieschlag E: Serum FHS and testicular morphology in male infertility. Clin Endocr 1994;40:133.
- Sharpe RM, Skakkebæk NE: Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 1993;341:1392.
- Müller J, Skakkebæk NE, Ritzén M, Plöen L, Petersen KE: Carcinoma in situ of the testis in children with 45,X/46,XY gonadal dysgenesis. J Pediatr 1985;106:431.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.